Chinese Journal of Pharmacovigilance ›› 2022, Vol. 19 ›› Issue (7): 712-716.
DOI: 10.19803/j.1672-8629.2022.07.04
Previous Articles Next Articles
ZHANG Dousheng, WANG Chen#, XU Mingzhe*
Received:
2022-02-15
Online:
2022-07-15
Published:
2022-07-12
CLC Number:
ZHANG Dousheng, WANG Chen, XU Mingzhe. Rapid evaluation of potential neurotoxicity of levornidazole for injection and its main impurities based on computational models and database technology[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 712-716.
[1] ZHANG Q, YAN JZ, YAO W, et al.Study on the legal system of drug reevaluation in america, european union, Japan and the Enlightenment to China[J]. China Pharmacy(中国药房), 2019, 30(18): 2449-2454. [2] ZHANG YP, SONG SY, BAO LL.Relationship between mechanism and chemical structure of adverse reactions of fluoroquinolones[J]. China & Foreign Medical Treatment(中外医疗), 2014, 33(7): 130-131. [3] GE YQ, YE XX, LE J, et al.Research progress on toxicity and detection methods of N-nitrosamines genotoxic impurities[J]. Chinese Journal of Pharmaceutical Analysis(药物分析杂志), 2020, 40(1): 83-89. [4] ADAMSON RH, CHABNER BA.The finding of N-nitrosod-imethylamine in common medicines[J]. The Oncologist, 2020, 25(6): 460-462. [5] MICHAEL WC.Understanding and preventing (N-nitrosod-imethylamine) NDMA contamination of medications[J]. The Annals of Pharmacotherapy, 2020, 54(6): 611-614. [6] HU JL, WU T, ZHU DM, et al.In vitro activity of a new antibac-terial agent levornidazole against anaerobic bacteria[J]. Chinese Journal of Infection and Chemotherapy(中国感染与化疗杂志), 2014, 14(2): 18-21. [7] LI WW, YAO MN, ZHAO X, et al.Systematic evaluation of levornidazole in the treatment of anaerobic infection[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2019, 28(3): 13-19. [8] HU J, ZHANG J, CHEN Y, et al.In vitro anaerobic pharma-cokinetic/ pharmacodynamic model to simulate the bactericidal activity of levornidazole against bacteroides fragilis[J]. Clinical Therapeutics, 2017, 39(4): 828-836. [9] ZHAO Y, CHEN Z, HUANG P, et al.Analysis of ornidazole injection in clinical use at post-marketing stage by centralized hospital monitoring system[J]. Current Medical Science, 2019, 39(5): 836-842. [10] SUN JH, WANG ZQ, GU XL, et al.Comparative study of ornidazole enantiomers on the toxic and side effects to central nervous system in mice[J]. Journal of China Pharmaceutical University(中国药科大学学报), 2008, 39(4): 343-347. [11] BAI YT, NAN N, YIN J.Discussion on toxicity prediction of quantitative structure-activity relationship model and its application in impurity prediction[J]. Chinese Pharmaceutical Affairs(中国药事), 2019, 33(10): 1174-1180. [12] LI L, YANG JB.Application progress of physiologically-based pharmacokinetic model in clinicaldevelopment of novel molecular entities[J]. Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2017, 33(17): 118-122. [13] PURI M, PATHAK YV, SUTATIYA VK, et al Artificial neural network for drug design, delivery and disposition[M]. Academic press: Salt lake city, USA, 2016: 181-193. [14] SAMUI P, ROY SS, VALENTINA EB.Handbook of neural computation[M]. Academic press: Salt Lake City, USA, 2017: 515-535. [15] GAO YF, FENG JF, ZHU L.Toxicodynamic modeling of zebrafish larvae to metals using stochastic death and individual tolerance models: comparisons of model assumptions, parameter sensitivity and predictive performance[J]. Ecotoxicology, 2017, 26(3): 295-307. [16] AUSTIN JD, HIRSTEIN J, WALEN S.Integrated mathematics interfaced with science[J]. School Science and Mathematics, 1997, 97(1): 45-49. [17] PABLO MC, PARDO-FERNÁNDEZ JC. The youden index in the generalized receiver operating characteristic curve context[J]. The International Journal of Biostatistics, 2019, 15(1): 1-20. [18] JOHN AC.Classical and modern regression with applications[J]. Technometrics, 2012, 29(3): 377-378. [19] KUHN M, LETUNIC I, JENSEN LJ, et al.The SIDER database of drugs and side effects[J]. Nucleic Acids Research, 2016, 44(D1): D1075-D1079. [20] LEI TL, LI YY, SONG YL, et al.ADMET evaluation in drug discovery: 15 accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling[J]. Journal of Cheminformatics, 2016, 8(1): 1-19. |
[1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
[2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
[4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
[5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
[6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
[9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
[10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
[12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
[14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
[15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||